The panel also mimics several aspects of human PDAC, such as subtypes with KRAS amplification, different routes of tumor development, such as chromothripsis, and a wide spectrum of genetic, morphological, and clinical heterogeneity (26). The gene discussed is KRAS; the disease is neoplasm.